Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lifecore Biomedical, Inc. \De\ (LFCR) Inventory Average (2016 - 2025)

Historic Inventory Average for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 17 years, with Q2 2025 value amounting to $33.4 million.

  • Lifecore Biomedical, Inc. \De\'s Inventory Average fell 1602.28% to $33.4 million in Q2 2025 from the same period last year, while for May 2025 it was $33.4 million, marking a year-over-year decrease of 1602.28%. This contributed to the annual value of $36.1 million for FY2025, which is 1057.91% down from last year.
  • Per Lifecore Biomedical, Inc. \De\'s latest filing, its Inventory Average stood at $33.4 million for Q2 2025, which was down 1602.28% from $36.9 million recorded in Q1 2025.
  • Lifecore Biomedical, Inc. \De\'s Inventory Average's 5-year high stood at $41.6 million during Q4 2023, with a 5-year trough of $31.9 million in Q1 2021.
  • Moreover, its 5-year median value for Inventory Average was $37.8 million (2021), whereas its average is $37.8 million.
  • Data for Lifecore Biomedical, Inc. \De\'s Inventory Average shows a peak YoY increase of 2490.66% (in 2021) and a maximum YoY decrease of 5098.52% (in 2021) over the last 5 years.
  • Lifecore Biomedical, Inc. \De\'s Inventory Average (Quarter) stood at $38.3 million in 2021, then dropped by 2.62% to $37.3 million in 2022, then rose by 11.48% to $41.6 million in 2023, then decreased by 2.74% to $40.4 million in 2024, then fell by 17.28% to $33.4 million in 2025.
  • Its Inventory Average stands at $33.4 million for Q2 2025, versus $36.9 million for Q1 2025 and $40.4 million for Q4 2024.